CSF1R and neoplasm: Thus, CSF1R inhibition reduces M2 macrophage marker expression and impairs the tumor-promoting activity of TAMs in tumors [24]; however, clinical studies have shown that the use of CSF1R inhibitors exerted very limited antitumor effects in patients.